AAPL 203.88 +0.14 (+0.07%)MSFT 123.45 +0.4 (+0.33%)FB 178.27 +0.03 (+0.02%)ZNGA 5.44 +0.09 (+1.59%)NVDA 186.25 +0.19 (+0.10%)WBA 54.62 -0.33 (-0.60%)GOOG 1237.48 -0.16 (-0.01%)PIH 5.25 -0.05 (-0.94%)
AAPL 203.88 +0.14 (+0.07%)MSFT 123.45 +0.4 (+0.33%)FB 178.27 +0.03 (+0.02%)ZNGA 5.44 +0.09 (+1.59%)NVDA 186.25 +0.19 (+0.10%)WBA 54.62 -0.33 (-0.60%)GOOG 1237.48 -0.16 (-0.01%)PIH 5.25 -0.05 (-0.94%)

Financial Summary ZFGN Quote Zafgen Inc.

Zafgen Inc. Quote

Zafgen Inc. (ZFGN)

2.61 0.02 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D+
Symbol ZFGN
Price 2.61
Beta -0.42
Vol Avg 225.78 K
Mkt cap 104.48 M
Shares 27
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -57.14% Strong Sell
ROA -46.43% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt/Equity 34.62% Neutral
P/E -1.36 Sell
P/B 0.90 Buy
Company Profile

CEO

Jeffrey S. Hatfield

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

Zafgen Inc is a biopharmaceutical company engaged in improving the health and well-being of patients affected by obesity and complex metabolic disorders. Its product candidate include Beloranib.